Canadian Hematology Conference 2020

Conférence Canadienne sur l’Hématologie 2020

We are celebrating the 10th Annual Canadian Hematology Conference.

CHC is going virtual this year!

 

It will be held on a virtual streaming platform on October 1st, 2nd and 3rd.

About CHC 2020

CHC is the largest multi-disciplinary hematological conference across Canada. It brings together a pan-Canadian and International Faculty to showcase cutting-edge research and developments in the field of hematology. This meeting covers a breadth of topics, including (but not limited to): Plasma Cell Dyscrasias, Non-Hodgkin’s Lymphoma, Hodgkin’s Disease, Chronic Lymphocytic Leukaemia, Myeloid Disease, Immunotherapy, Thrombosis and Benign Disorders.

Dr. John Kuruvilla (Princess Margaret Cancer Centre) and Dr. Peter Anglin (Stronach Regional Cancer Centre) will co-chair this event. CHC 2020 is open to Canadian hematology professionals, including residents, nurses, pharmacists, and specialists who have an interest in hematology.

Event Details

Date

Thursday, October 1st
Friday, October 2nd
Saturday, October 3rd

Time

Thursday:  12 pm – 5:30pm
Friday:  12 pm – 6pm
Saturday:  9 am – 2 pm

Register to gain access to:

  • Leading clinical presentations
  • Panelist discussions
  • First access to clinical slide decks
  • Follow-up Q&A with CHC speakers
  • Year-round access to recorded CHC 2020 presentations

Event Chairs

Dr. John Kuruvilla
(Princess Margaret Cancer Centre)

Dr. Peter Anglin
(Stronach Regional Cancer Centre)

Agenda

Thursday, October 1st

Plasma cell dyscrasias

  • Chris Venner, MD – Alberta Health Services
  • Keith Stewart, MD – Princess Margaret Cancer Centre
  • Kevin Song, MD – BC Cancer

Chronic Lymphocytic Leukemia

  • Michael Hallek, MD – University Hospital Cologne (Germany)
  • Carolyn Owen, MD – Alberta Health Services

Immunotherapy

  • Rob Laister (Clinical Researcher) – Princess Margaret Cancer Centre
  • Ronan Foley, MD – McMaster University
  • John Kuruvilla, MD – Princess Margaret Cancer Centre

Friday, October 2nd

Non-Hodgkin lymphoma I

  • Frederick Locke, MD – Moffitt Cancer Center (Florida, USA)
  • Michael Crump, MD – Princess Margaret Cancer Centre
  • Richard Tsang , MD – Princess Margaret Cancer Centre

Leukemia & MDS  

  • Rena Buckstein, MD – Sunnybrook Hospital
  • Vikas Gupta, MD – Princess Margaret Cancer Centre

Hodgkin lymphoma

  • John Kuruvilla, MD – Princess Margaret Cancer Centre
  • David Hodgson, MD – Princess Margaret Cancer Centre

Saturday, October 3rd

Non-Hodgkin lymphoma II

  • Martin Dreyling, MD – University of Munich (Germany)
  • Catherine Thieblemont, MD – Hôpital Saint-Louis (France) or
  • Emanuele Zucca, MD – Oncology Institute of Southern Switzerland
  • Steve Treon, MD – Harvard University (Massachusetts, USA)

Translational Science

  • Robert Kridel, MD – Princess Margaret Cancer Centre
  • Marcus Butler, MD – Princess Margaret Cancer Centre

Access to innovation and closing remarks

More speakers to be announced at a later date.
Check out the CHC 2020 event page on Facebook to connect with other attendees!